Horizon Therapeutics Public Ltd Co Accrued Liabilities, Current
Horizon Therapeutics Public Ltd Co had Accrued Liabilities, Current of $496.67 million as of 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2023-08-08
- 2023-06-30: Accrued Liabilities, Current $496.67M.
- 2023-03-31: Accrued Liabilities, Current $482.33M.
- 2022-12-31: Accrued Liabilities, Current $457.56M.
- 2022-09-30: Accrued Liabilities, Current $457.29M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2023-06-30 | $496.67M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $482.33M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $457.56M 10-Q · filed 2023-08-08 | |
| 2022-09-30 | $457.29M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $419.04M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $377.43M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $523.01M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $483.83M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $478.50M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $389.63M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $485.57M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $421.83M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $415.55M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $205.99M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $235.23M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $204.16M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $188.19M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $197.24M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $215.74M 10-K · filed 2020-02-26 | $205.59M 10-K · filed 2019-02-27 |
| 2018-09-30 | $194.85M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $173.62M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $180.45M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $175.70M 10-K · filed 2019-02-27 | $137.83M 10-K · filed 2018-02-28 |
| 2017-09-30 | $162.70M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $112.45M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $144.85M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $182.76M 10-K · filed 2018-02-28 | |
| 2016-09-30 | $157.53M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $75.71M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $89.14M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $100.05M 10-K · filed 2017-02-27 | |
| 2015-09-30 | $84.36M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $79.25M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $46.13M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $46.63M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $39.43M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $19.24M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $44.71M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $15.93M 10-K/A · filed 2015-03-02 | $24.05M 10-K · filed 2014-03-13 |
| 2013-09-30 | $22.91M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $20.52M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $15.02M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $16.78M 10-K · filed 2014-03-13 | |
| 2012-09-30 | $12.61M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $11.15M 10-Q · filed 2012-08-10 | |
| 2012-03-31 | $9.01M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $8.93M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $6.43M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $6.89M 10-Q · filed 2011-09-02 | |
| 2010-12-31 | $6.73M 10-K · filed 2012-03-23 |